News

Published on 4 Apr 2024 on Medscape

Heart-1 Gene Therapy Trial Pauses Enrollment

Article preview image

A phase 1 gene editing trial in patients with heterozygous familial hypercholesterolemia and atherosclerotic CVD was paused after abnormal lab results...

Read the rest of the article
NASDAQ.VERV price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
Cathie Wood's ARK sells more Coinbase stock, buys Roblox By Investing.com

Cathie Wood's ARK sells more Coinbase stock, buys Roblox

Investing.com 4 Apr 2024
Heart-1 Gene Therapy Trial Pauses Enrollment

A phase 1 gene editing trial in patients with heterozygous familial hypercholesterolemia and athe...

Medscape 4 Apr 2024
Cathie Wood's Ark Invest Buys More Shares Of This Meta Platforms Competitor - ARK Fintech Innovation...

On Wednesday, Cathie Wood’s Ark Invest made a significant move by purchasing additional shares of...

Benzinga 4 Apr 2024
Cathie Wood's ARK shifts focus, buys Datadog and sells Twilio stock

Cathie Wood's ARK shifts focus, buys Datadog and sells Twilio stock

Investing.com 4 Apr 2024
Verve Falls as Gene-Editing Trial Paused on Safety Issues

(Bloomberg) -- Verve Therapeutics Inc. shares tumbled after it cited safety concerns for pausing ...

Bloomberg via Yahoo Finance 2 Apr 2024
Why Is Verve Therapeutics Stock Trading Lower On Tuesday? - Verve Therapeutics (NASDAQ:VERV)

Verve Therapeutics Inc VERV announced an update from the Heart-1 Phase 1b trial of VERVE-101. VER...

Benzinga 2 Apr 2024
New Forecasts: Here's What Analysts Think The Future Holds For Verve Therapeutics, Inc....

Verve Therapeutics, Inc. (NASDAQ:VERV) shareholders will have a reason to smile today, with the a...

Simply Wall St. via Yahoo Finance 29 Feb 2024
Verve Therapeutics, Inc. (NASDAQ:VERV) is a favorite amongst institutional investors who own 64%

Key Insights Institutions' substantial holdings in Verve Therapeutics implies that they have sign...

Simply Wall St. via Yahoo Finance 29 Jan 2024
The Petri Dish: Flagship opens U.K. hub, FDA warns of complications from CAR-Ts - Boston Business...

Innovators across Massachusetts' life sciences industry are busy developing drugs and devices to...

The Business Journals 30 Nov 2023
Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket By Benzinga

Why Workday Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket

Investing.com 29 Nov 2023

Copyright Statfolio @ 2024

Social Accounts